Skip to content

The Efficacy of Perioperative Intravenous Acetaminophen for Off-pump CABG

The Efficacy of Perioperative Intravenous Acetaminophen for Off-pump CABG - The Study of Acetaminophen for the Prevention Of Pain and the Reduction Of Pain-RelIever and AnTiEmetics: APPROPRIATE Study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015653
Enrollment
150
Registered
2014-11-11
Start date
2014-11-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angina pectoris, old/subacute myocardial infarction, post operative pain

Interventions

Patients are given the study drugs 8 times every 6 hours from 30 minutes before the start of surgery to post operative day 2. Study Drugs Intervention group: intravenous acetaminophen 15mg/kg(1.5ml/

Sponsors

IMS Katsushika Heart Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Ischemic heart disease patients who have off-pump coronary artery bypass grafting surgery.

Exclusion criteria

Exclusion criteria: Fraility scale>=5 Disability of expressing pain Patients of converting the surgery to on-pump coronary artery bypass grafting surgeries Patients using intra-aortic balloon pumping or extracorporeal membrane oxygenation devises The nutritionally-depleted patient: body mass index<18.5 or serum albumin level<3.5g/dl Patients with liver disease: chronic virus hepatitis, alcoholic hepatitis, chronic cirrhosis Preoperative blood abnormal value of AST(aspartate aminotransferase)>=120U/l, ALT(alanine aminotransferase)>=135U/l, total bilirubin>=2.4mg/dl Hemodialysis patients Impaired renal function: serum creatinine level>=3.0mg/dl Patients with aspirin-induced asthma Patients who are taking vitamin K antagonist, isoniazid, carbamazepine, phenobarbital, phenytoin, primidone, rifampicin Patients with the allergy to acetaminophen

Design outcomes

Primary

MeasureTime frame
Postoperative pain scale at 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, 42, 45 hours after ICU admission and at the morning of POD3,4,5 and at the discharge: including Behavioral Pain Scale, Visual Analog Scale, Numerical Rating Scale The total amount of morphine consumption for pain reliever The incidence of postoperative nausea and vomiting during ICU stay

Secondary

MeasureTime frame
Intra- and post-operative bleeding volume Postoperative serum AST(aspartate aminotransferase), ALT(alanine aminotransferase), total bilirubin, alkaline phosphatase value Postoperative blood platelet counts, prothrombin time, PT-INR, activated partial thromboplastin time Postoperative renal function: serum creatinine level and the rate of variability against the preoperative value The duration of mechanical ventilation The duration of ICU stay The progress of postoperative rehabilitation by POD3 The incidence of postoperative adverse events

Countries

Japan

Contacts

Public ContactToshihiro Nohmi

IMS Katsushika Heart Center Anesthesiology

t.nohmi@ims.gr.jp03-3694-8100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026